<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Masimo Corporation</title>
	<atom:link href="http://www.stockbloghub.com/tag/masimo-corporation/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Wed, 23 May 2012 20:22:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(MASI) Masimo Wins New Customer Nassau University Medical Center</title>
		<link>http://www.stockbloghub.com/2010/04/18/masi-masimo-wins-new-customer-nassau-university-medical-center/34100</link>
		<comments>http://www.stockbloghub.com/2010/04/18/masi-masimo-wins-new-customer-nassau-university-medical-center/34100#comments</comments>
		<pubDate>Mon, 19 Apr 2010 01:40:33 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MASI]]></category>
		<category><![CDATA[Masimo Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=34100</guid>
		<description><![CDATA[Masimo Corp. (MASI) recently reported that its new customer, Nassau University Medical Center (NUMC), has completed its system-wide conversion to Masimo SET pulse oximetry technology. The conversion allows clinicians to monitor NUMC patients non-invasively using the latest pulse oximetry technology. This in turn provides real time data for vital parameters that aid clinicians in faster and accurate patient treatments. Masimo SET pulse oximetry enables clinicians to continuously and non-invasively measure multiple blood constituents that previously required invasive procedures. The multiple blood constituents measured are total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), oxyhemoglobin (SpO2), methemoglobin (SpMet), acoustic respiration rate (RRa), pulse rate (PR), and perfusion index (PI), etc. Masimo SET pulse oximetry eliminates the need to draw blood and wait for results. This helps physicians to immediately detect and treat ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/18/masi-masimo-wins-new-customer-nassau-university-medical-center/34100/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MASI) Masimo Analysts Maintain Neutral Rating</title>
		<link>http://www.stockbloghub.com/2010/03/17/masi-masimo-analysts-maintain-neutral-rating/30936</link>
		<comments>http://www.stockbloghub.com/2010/03/17/masi-masimo-analysts-maintain-neutral-rating/30936#comments</comments>
		<pubDate>Wed, 17 Mar 2010 19:33:16 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MASI]]></category>
		<category><![CDATA[Masimo Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=30936</guid>
		<description><![CDATA[We continue to maintain our ‘Neutral’ rating on Masimo Corp. (MASI) with a target price of $28 based on a P/E of 28.0x our fiscal 2010 EPS estimate of $1. The company’s fourth quarter fiscal 2009 results reflect a mixed trend. Masimo reported fourth-quarter earnings per share of 23 cents, surpassing the Zacks Consensus Estimate of 22 cents. However, earnings was lower than the year-ago figure of 24 cents. For fiscal 2009, earnings per share was 88 cents, in line with the Zacks Consensus Estimate and higher than 78 cents, a year-ago. Total revenue in the fourth quarter increased 11% year over year to $92.6 million. Product revenue increased 12% year over year to $80.5 million. Royalty revenue increased 6% year over year to $12.2 million. Growth in product revenue ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/17/masi-masimo-analysts-maintain-neutral-rating/30936/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MASI) Masimo Corporation Announces Positive Results From Clinical Study</title>
		<link>http://www.stockbloghub.com/2010/01/25/masi-masimo-corporation-announces-positive-results-from-clinical-study/25894</link>
		<comments>http://www.stockbloghub.com/2010/01/25/masi-masimo-corporation-announces-positive-results-from-clinical-study/25894#comments</comments>
		<pubDate>Mon, 25 Jan 2010 20:30:54 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MASI]]></category>
		<category><![CDATA[Masimo Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=25894</guid>
		<description><![CDATA[Masimo Corporation (MASI) recently announced positive results form its 21-month clinical study on the impact of the Masimo Patient SafetyNet remote monitoring and clinician notification system. Results indicated that continuous pulse oximetry monitoring and clinician notification in post-surgical patients on the general floor leads to a significant drop in key clinical outcome measures, such as 65% fewer rescue events, 48% fewer ICU transfers and reduced annualized ICU time by 135 days. Masimo Patient SafetyNet combines the performance of Masimo SET pulse oximetry at the point of care with remote monitoring and wireless clinician notification via pager. This is the first study on adults using Masimo SET pulse oximetry technology that demonstrated improved patient safety while reducing the cost. Masimo SET pulse oximetry enables clinicians to continuously and non-invasively measure multiple ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/25/masi-masimo-corporation-announces-positive-results-from-clinical-study/25894/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MASI) Masimo Corporation Can Now Earn While Patients Test Device Effectiveness</title>
		<link>http://www.stockbloghub.com/2010/01/05/masi-masimo-corporation-can-now-earn-while-patients-test-device-effectiveness/24122</link>
		<comments>http://www.stockbloghub.com/2010/01/05/masi-masimo-corporation-can-now-earn-while-patients-test-device-effectiveness/24122#comments</comments>
		<pubDate>Tue, 05 Jan 2010 18:29:56 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MASI]]></category>
		<category><![CDATA[Masimo Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24122</guid>
		<description><![CDATA[Masimo Corporation (MASI) has recently received a new Current Procedural Terminology (CPT) code from the American Medical Association, 88738, for its noninvasive hemoglobin (SpHb) measurement. Medicare has priced the new CPT code at $7.19 on its 2010 Medicare Clinical Laboratory Fee Schedule. The new pricing has been effective since Jan 1, 2010. The new CPT code is an important milestone for Masimo. It will now permit health care providers to bill and receive payments from Medicare when testing eligible patients. This in turn will encourage them to use Masimo’s SpHb measurement  devices that will expand the company’s top line. Masimo develops, manufactures and markets a family of non-invasive blood monitoring systems that consist of a monitor, circuit board and sensors. The systems are primarily used to monitor blood oxygen saturation ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/05/masi-masimo-corporation-can-now-earn-while-patients-test-device-effectiveness/24122/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical Corporation Earns FDA Clearance</title>
		<link>http://www.stockbloghub.com/2010/01/01/zoll-zoll-medical-corporation-earns-fda-clearance/24040</link>
		<comments>http://www.stockbloghub.com/2010/01/01/zoll-zoll-medical-corporation-earns-fda-clearance/24040#comments</comments>
		<pubDate>Sat, 02 Jan 2010 02:28:28 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[MASI]]></category>
		<category><![CDATA[Masimo Corporation]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24040</guid>
		<description><![CDATA[Recently, ZOLL Medical Corporation (ZOLL) announced that the U.S. Food and Drug Administration (FDA) approved the marketing of its E series defibrillators equipped with carbon monoxide (CO) monitoring. The new model of the ZOLL E series monitor/defibrillator is available for shipment with immediate effect. The presence of CO monitoring in the new model is an impressive feature. It will protect firefighters, civilians and treat patients poisoned by CO immediately. If someone is continuously exposed to the gas then his heart and brain are liable to be affected in the long term. Furthermore, a solitary severe case of CO poisoning almost doubles the risk of premature demise. People poisoned by this gas often display flu-like symptoms. However, it is also possible that people poisoned by this “silent killer&#8221; do not display ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/01/zoll-zoll-medical-corporation-earns-fda-clearance/24040/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MASI) Masimo Corporation in Expansion Mode</title>
		<link>http://www.stockbloghub.com/2009/12/29/masi-masimo-corporation-in-expansion-mode/23870</link>
		<comments>http://www.stockbloghub.com/2009/12/29/masi-masimo-corporation-in-expansion-mode/23870#comments</comments>
		<pubDate>Wed, 30 Dec 2009 01:04:32 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[COV]]></category>
		<category><![CDATA[Covidien plc]]></category>
		<category><![CDATA[MASI]]></category>
		<category><![CDATA[Masimo Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=23870</guid>
		<description><![CDATA[Masimo Corp. (MASI) recently announced the expansion of its corporate campus in Irvine, California with the addition of an adjacent 32,000 sq. ft. building. This is the company&#8217;s third building on its corporate campus. Masimo stated that the new building is expected to accommodate more than 200 employees. The expansion of Masimo’s corporate headquarters will further strengthen its engineering, sales and administrative functions in 2010. These are required to accommodate the increasing demand for its breakthrough medical technologies Incorporatedluding the expansion of its Masimo Rainbow SET Pulse CO-Oximetry and new Acoustic Monitoring business. The current year alone has seen more than 150 hospitals throughout the world adapt the company’s advanced pulse oximetry technology. As a reminder, earlier this month, Masimo’s new customer, Brookdale University Hospital and Medical Center in Brooklyn, New ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/29/masi-masimo-corporation-in-expansion-mode/23870/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MASI) Masimo Completes Conversion of New Customer</title>
		<link>http://www.stockbloghub.com/2009/12/14/masi-masimo-completes-conversion-of-new-customer/22770</link>
		<comments>http://www.stockbloghub.com/2009/12/14/masi-masimo-completes-conversion-of-new-customer/22770#comments</comments>
		<pubDate>Tue, 15 Dec 2009 01:30:13 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MASI]]></category>
		<category><![CDATA[Masimo Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=22770</guid>
		<description><![CDATA[Masimo Corp. (MASI) reported that its new customer, Brookdale University Hospital and Medical Center in Brooklyn, New York, has completed its system-wide conversion to Masimo SET pulse oximetry technology. Brookdale has also installed Masimo’s first-ever continuous and noninvasive hemoglobin monitoring (SpHb) technology in its select care settings. This allows clinicians to detect and treat chronic or acute anemia earlier, more effectively manage blood transfusions for their patients and identify internal bleeding quicker. The Brookdale University Hospital and Medical Center is one of the largest voluntary nonprofit teaching hospitals in Brooklyn and a New York State Department of Health (DOH) designated Stroke Center. Masimo SET pulse oximetry enables clinicians to continuously and non-invasively measure multiple blood constituents that previously required invasive procedures. The multiple blood constituents measured are total hemoglobin (SpHb), ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/14/masi-masimo-completes-conversion-of-new-customer/22770/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MASI) Masimo Corporation Earns FDA New Product Approval</title>
		<link>http://www.stockbloghub.com/2009/12/02/masi-masimo-corporation-earns-fda-new-product-approval/21799</link>
		<comments>http://www.stockbloghub.com/2009/12/02/masi-masimo-corporation-earns-fda-new-product-approval/21799#comments</comments>
		<pubDate>Wed, 02 Dec 2009 22:21:48 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MASI]]></category>
		<category><![CDATA[Masimo Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=21799</guid>
		<description><![CDATA[Masimo Corporation (MASI) recently received the U.S. Food and Drug Administration (FDA) approval for its new product, Masimo Rainbow SET Acoustic Monitoring. The new product enables noninvasive and continuous monitoring of human respiration rate (RRa). The data provided is accurate, easy-to-use, and thereby enhances patient compliance. With the approval, Masimo expects to launch the product in a limited market release in the U.S. in this month. The new product enables earlier detection of respiratory compromise and patient distress. This is especially important for post-surgical patients receiving patient-controlled analgesia for pain management. It is seen that these patients often suffer from respiratory problems due to sedation, which can result in serious injury or even death. Masimo Rainbow SET Acoustic Monitoring also eliminates the lack of accuracy and patient compliance issues prevalent ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/02/masi-masimo-corporation-earns-fda-new-product-approval/21799/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MASI) Masimo Corporation Renews Deal with Advocate Health Care</title>
		<link>http://www.stockbloghub.com/2009/11/29/masi-masimo-corporation-renews-deal-with-advocate-health-care/21455</link>
		<comments>http://www.stockbloghub.com/2009/11/29/masi-masimo-corporation-renews-deal-with-advocate-health-care/21455#comments</comments>
		<pubDate>Mon, 30 Nov 2009 04:25:19 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MASI]]></category>
		<category><![CDATA[Masimo Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=21455</guid>
		<description><![CDATA[Masimo Corporation (MASI) announced that one of its prominent customers, Advocate Health Care, has recently renewed its multi-year, system-wide contract for Masimo SET pulse oximetry technology. Advocate Health Care is Illinois&#8217; largest and one of the top ten health care providers in the U.S. It has more than 200 patient-care sites across Chicago. Financial terms of the contract have not been disclosed. Advocate Health Care has been Masimo’s customer since 2001. The contract enables Masimo to support the pulse oximetry needs of more than 200 sites of Advocate Health Care. This will in turn boost Masimo’s top-line. Masimo Corporation develops, manufactures and markets a family of non-invasive blood monitoring systems that consist of a monitor, circuit board and sensors. The systems are primarily used to monitor blood oxygen saturation levels ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/29/masi-masimo-corporation-renews-deal-with-advocate-health-care/21455/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CFN) CareFusion Corporation Enters Agreement with Masimo</title>
		<link>http://www.stockbloghub.com/2009/11/14/masi-carefusion-corporation-enters-agreement-with-masimo/20535</link>
		<comments>http://www.stockbloghub.com/2009/11/14/masi-carefusion-corporation-enters-agreement-with-masimo/20535#comments</comments>
		<pubDate>Sat, 14 Nov 2009 22:12:01 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Instruments & Supplies]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[CAH]]></category>
		<category><![CDATA[Cardinal Health Inc.]]></category>
		<category><![CDATA[Carefusion Corporation]]></category>
		<category><![CDATA[CFN]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MASI]]></category>
		<category><![CDATA[Masimo Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=20535</guid>
		<description><![CDATA[CareFusion Corp. (CFN) entered into a multi-year technology licensing agreement with Masimo Corp. (MASI) regarding the use of Masimo Rainbow SET Pulse CO-Oximetry technology in CareFusion infusion and respiratory products, which are presently under development. The agreement enables CareFusion’s future infusion and respiratory products to non-invasively and continuously measure multiple blood constituents to more accurately assess dyshemoglobins affecting oxygenation, predict fluid responsiveness, and provide earlier identification of respiratory compromise. CareFusion’s ventilators and infusion pumps facilitate earlier detection, diagnosis and treatment of potentially life-threatening conditions by accessing total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet), and PVI for fluid responsiveness, in addition to oxyhemoglobin (SpO2), perfusion index (PI), and pulse rate. CareFusion is a medical technology company formed recently by the spin-off of the Clinical and Medical Products business ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/14/masi-carefusion-corporation-enters-agreement-with-masimo/20535/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

